PROFUSE TECHNOLOGY LTD

General Data

Reg Number
516412665
Sector
Biomed
Established
2021
No. of Employees
15
Stage
R&D
Additional Funding
0

Technology

ProFuse's technology is based on a six years groundbreaking study by the Weizmann Institute of Science led by Professor Eldad Tzahor - a world-renowned expert in the field of embryonic development and cell regeneration, Dr. Ori Avinoam who specializes in intercellular fusion and tissue formation, and Dr. Tamar Eigler who specializes in stem cell biology muscle. The company specializes on muscle cultivation. ProFuse’s products for the cultivated meat sector include cell lines and media supplements which reduces production time, increase yield and enhances the production capacity of cultured meat by accelerating muscle fiber growth. Life Science customers use ProFuse media supplements and proprietary cell line that were customized with unique reporters to discover drugs for treating muscle atrophy. The solutions and additives offered are based on the activation (patent pending) of a biochemical signaling pathway which acts at two distinct phases of myogenesis, by accelerating differentiation and enhancing fusion of myoblasts.

Targeted Customers

Cell culture media producers, cultured meat A-Z vendors

Management personnel

Guy Michrowski - CEO & Co-Founder
Tamar Eigler-Hirsh - CTO & Co-Founder

Contact information

Name
Website
http://www.profuse-tech.com
Country
Israel

Tags

AgrifoodAlternative ProteinsBiotechnologyCultivated MeatDrug DiscoveryFoodTechLife SciencesMedTech

Classified Technologies

Biotechnology and industrial biology

Winning details

Route name
Winning year

R&D Program
R&D Program
2023